Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus

American Journal of Cardiology

Volumn 112, Issue 1, 2013, Pages 73-78

  Rao, Ajay D ^a   Shah, Ravi V ^a,b   Garg, Rajesh ^a   Abbasi, Siddique A ^a   Neilan, Tomas G ^a,b   Perlstein, Todd S ^a   Di Carli, Marcelo F ^a   Jerosch Herold, Michael ^a   Kwong, Raymond Y ^a   Adler, Gail K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; BLOOD PRESSURE; BODY MASS; CONFERENCE PAPER; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FEMALE; GLYCEMIC CONTROL; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; ALDOSTERONE; BIOLOGICAL MARKERS; CONTRAST MEDIA; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXTRACELLULAR MATRIX; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 84879119227     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.02.060     Document Type: Conference Paper

References (30)

1. A.M. From, C.G. Scott, and H.H. Chen The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction: a population-based study J Am Coll Cardiol 55 2010 300 305
2. K.K.L. Ho, J.L. Pinsky, W.B. Kannel, and D. Levy The epidemiology of heart failure - the Framingham Study J Am Coll Cardiol 22 1993 A6 A13
3. T.J. Regan, M.M. Lyons, S.S. Ahmed, G.E. Levinson, H.A. Oldewurtel, M.R. Ahmad, and B. Haider Evidence for cardiomyopathy in familial diabetes mellitus J Clin Invest 60 1977 885 899
4. M.F. Di Carli, J. Janisse, G. Grunberger, and J. Ager Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes J Am Coll Cardiol 41 2003 1387 1393
5. A.C.T. Ng, D. Auger, V. Delgado, S.G.C. van Elderen, M. Bertini, H.-M. Siebelink, R.J. van der Geest, C. Bonetti, E.T. van der Velde, A. de Roos, J.W.A. Smit, D.Y. Leung, J.J. Bax, and H.J. Lamb Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T1 mapping and subclinical myocardial dysfunction in diabetic patients Circ Cardiovasc Imaging 5 2012 51 59
6. J.K. Boyer, S. Thanigaraj, K.B. Schechtman, and J.E. Perez Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus Am J Cardiol 93 2004 870 875
7. R. Rocha, C.T. Stier, I. Kifor, M.R. Ochoa-Maya, H.G. Rennke, G.H. Williams, and G.K. Adler Aldosterone: a mediator of myocardial necrosis and renal arteriopathy Endocrinol 141 2000 3871 3878
8. C.G. Brilla, and K.T. Weber Mineralocorticoid excess, dietary sodium, and myocardial fibrosis J Lab Clin Med 120 1992 893 901
9. M. Young, G. Head, and J. Funder Determinants of cardiac fibrosis in experimental hypermineralocorticoid states Am J Physiol Endocrinol Metab 269 1995 E657 E662
10. J.M. DeOliveira, D.A. Price, N.D.L. Fisher, D.R. Allan, J.A. McKnight, G.H. Williams, and N.K. Hollenberg Autonomy of the renin system in type II diabetes mellitus: dietary sodium and rectal hemodynamic responses to ACE inhibition Kidney Int 52 1997 771 777
11. M. Epstein, G.H. Williams, M. Weinberger, A. Lewin, S. Krause, R. Mukherjee, R. Patni, and B. Beckerman Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes Clin J Am Soc Nephrol 1 2006 940 951
12. F. Zannad, F. Alla, B. Dousset, A. Perez, and B. Pitt Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES) Circulation 102 2000 2700 2706
13. M.F. Di Carli, D. Bianco-Batlles, M.E. Landa, A. Kazmers, H. Groehn, O. Muzik, and G. Grunberger Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus Circulation 100 1999 813 819
14. A. Farzaneh-Far, V. Ariyarajah, C. Shenoy, J.-F. Dorval, M. Kaminski, Z. Curillova, H. Wu, K.B. Brown, and R.Y. Kwong Left atrial passive emptying function during dobutamine stress MR imaging is a predictor of cardiac events in patients with suspected myocardial ischemia JACC Cardiovasc Imaging 4 2011 378 388
15. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M. St John Sutton, and W.J. Stewart Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
16. C.S. Broberg, S.S. Chugh, C. Conklin, D.J. Sahn, and M. Jerosch-Herold Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease Circulation-Cardiovasc Imaging 3 2010 727 734
17. M. Jerosch-Herold, D.C. Sheridan, J.D. Kushner, D. Nauman, D. Burgess, D. Dutton, R. Alharethi, D. Li, and R.E. Hershberger Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy Am J Physiol Heart Circ Physiol 295 2008 H1234 H1242
18. American Diabetes Association Standards of medical care in diabetes - 2012 Diabetes Care 35 2012 S11 S63
19. M. Ugander, A.J. Oki, L.-Y. Hsu, P. Kellman, A. Greiser, A.H. Aletras, C.T. Sibley, M.Y. Chen, W.P. Bandettini, and A.E. Arai Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology Eur Heart J 33 2012 1268 1278
20. G. Suzuki, H. Morita, T. Mishima, V.G. Sharov, A. Todor, E.J. Tanhehco, A.E. Rudolph, E.G. McMahon, S. Goldstein, and H.N. Sabbah Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure Circulation 106 2002 2967 2972
21. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, and J. Wittes The Randomized Aldactone Evaluation Study I. The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
22. B. Pitt, N. Reichek, R. Willenbrock, F. Zannad, R.A. Phillips, B. Roniker, J. Kleiman, S. Krause, D. Burns, and G.H. Williams Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-Left Ventricular Hypertrophy Study Circulation 108 2003 1831 1838
23. W. Kosmala, M. Przewlocka-Kosmala, H. Szczepanik-Osadnik, A. Mysiak, T. O'Moore-Sullivan, and T.H. Marwick A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome JACC Cardiovasc Imaging 4 2011 1239 1249
24. D.R. Messroghli, S. Nordmeyer, T. Dietrich, O. Dirsch, E. Kaschina, K. Savvatis, D.O. H-Ici, C. Klein, F. Berger, and T. Kuehne Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping Circ Cardiovasc Imaging 4 2011 636 640
25. S.K. White, D.M. Sado, A.S. Flett, and J.C. Moon Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging Heart 98 2012 773 779
26. A.W. Krug, L.H. Pojoga, G.H. Williams, and G.K. Adler Cell membrane-associated mineralocorticoid receptors? Hypertension 57 2011 1019 1025
27. H.V. Joffe, R.Y. Kwong, M.D. Gerhard-Herman, C. Rice, K. Feldman, and G.K. Adler Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus J Clin Endocrinol Metab 92 2007 2552 2558
28. A.M. Briones, A. Nguyen Dinh Cat, G.E. Callera, A. Yogi, D. Burger, Y. He, J.W. Corrêa, A.M. Gagnon, C.E. Gomez-Sanchez, E.P. Gomez-Sanchez, A. Sorisky, T.C. Ooi, M. Ruzicka, K.D. Burns, and R.M. Touyz Adipocytes produce aldosterone through calcineurin-dependent signaling pathways Hypertension 59 2012 1069 1078
29. T.L. Goodfriend, B.M. Egan, and D.E. Kelley Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans Prostaglandins Leukot Essent Fatty Acids 60 1999 401 405
30. J.H. Li, X.R. Huang, H.-J. Zhu, M. Oldfield, M. Cooper, L.D. Truong, R.J. Johnson, and H.Y. Lan Advanced glycation end products activate Smad signaling via TGF-β-dependent and -independent mechanisms: implications for diabetic renal and vascular disease FASEB J 18 2004 176 178